[Feasibility study of lung ultrasound in the follow-up of neonatal lung diseases]

【肺部超声在新生儿肺部疾病随访中的可行性研究】

阅读:1

Abstract

OBJECTIVES: To explore the feasibility of lung ultrasound in the follow-up of neonatal lung disease. METHODS: A retrospective study was conducted of 102 infants with neonatal lung disease who were followed up in the Department of Neonatology, the First Affiliated Hospital of Zhengzhou University from March to July 2025. According to follow-up lung ultrasound results, infants were classified into a normal group and an abnormal group. Baseline and clinical characteristics were compared between groups. Multivariable logistic regression was performed to identify independent influencing factors of abnormal lung ultrasound at follow-up, and a prediction model was constructed. Its performance for predicting abnormal lung ultrasound at follow-up was evaluated using receiver operating characteristic (ROC) curve analysis. RESULTS: The median follow-up duration was 32 days, and 58 infants (56.9%) had abnormal lung ultrasound. Significant differences were found between the normal and abnormal groups in gestational age, birth weight, and follow-up duration (all P<0.05). Multivariable logistic regression showed that gestational age (OR=0.617, P<0.001) and follow-up duration (OR=0.976, P<0.001) were independent protective factors against abnormal lung ultrasound at follow-up. ROC analysis indicated that the combined model constructed with gestational age and follow-up duration, logit(P)=17.001-0.025×follow-up duration-0.483×gestational age (where P is the probability of abnormal lung ultrasound at follow-up), achieved an area under the curve of 0.833 (95%CI: 0.758-0.909, P<0.001), with a sensitivity of 62.1% and a specificity of 93.2%. The goodness of fit was good (P>0.05). CONCLUSIONS: Lung ultrasound is feasible for the follow-up of neonatal lung diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。